PREVENAR 13
Suspension for injection (0,5 ml). Pack sizes of 1 and 10 with or without needles and a multi pack of 5 packs of 10 transparent 0 5 ml glass pre-filled syringes with or without needles.
registration number
44/30.1/0002
What PREVENAR 13 is and what it is used for
PREVENAR 13 helps protect you or your child
against diseases such as meningitis, sepsis or bacteraemia (bacteria in blood stream),
pneumonia and ear infection caused by thirteen types of the bacteria Streptococcus
pneumoniae.
The vaccine works by helping the body to make its own antibodies, which help protect the
individual against these diseases.
dosage
The vaccine is a ready-to-use suspension for injection and is provided in a single dose
pre-filled syringe (0,5 ml).
how to take
The doctor or nurse will inject the recommended dose (0,5 ml) of the vaccine into your child’s,
or your arm or leg muscle.
Infants, children and adolescents 6 weeks to 17 years of age:
Typically, your child should receive four doses of the vaccine. However, the number of
required doses will vary, depending on age and previous vaccinations. Each dose will be
given on a separate occasion. It is important to follow the instructions from the doctor/nurse
so that your child completes the correct course of injections.
PREVENAR 13 can be given at the same time as other childhood vaccines; in this case,
different injection-sites should be used.
If you forget to go back to the doctor or nurse at the scheduled time, ask the doctor or nurse
for advice. If you have any further questions on the use of PREVENAR 13 ask your doctor.
Adults aged 18 years and older: PREVENAR 13 is to be administered as a single dose to
adults 18 years and older including those previously vaccinated with a pneumococcal
polysaccharide vaccine.
The need for re-vaccination with a subsequent dose of PREVENAR 13 has not been
established. For specific guidelines, please refer to local recommendations.
What PREVENAR 13 contains
2,2 micrograms of saccharide for serotypes 1, 3, 4, 5, 6A, 7F, 9V, 14, 18C, 19A, 19F
and 23F; and
- 4,4 micrograms of saccharide for serotype 6B.
other ingredients
sodium chloride, succinic acid, polysorbate 80 and water for
injection.
Therapeutic classification
J07AL02.